Mitsui Chemicals to Launch Full-Scale Production Facility for Plasma Display Panel Optical Filters

Mitsui Chemicals (MCI), anticipating a surge in demand for film-type PDP optical filters, is building a new mass-production facility and commercial operations.

In its current Medium-term Business Plan, MCI aims to expand and grow the Performance Materials ranging from functional polymers, IT and electronics materials and healthcare materials. In its business strategy, MCI further expands and grows the PDP optical filter business, a core product in IT and electronics materials, by providing products and services to fulfill high client-satisfaction level from its customers’ perspective.

PDP demand is expected to surge at an annual rate of over 30% by 2007. The glass-type optical filters (MCI’s trade name: FILTOPTM) have been mainly used in PDP, but film-type optical filters, which make PDP much thinner and lighter in addition to improving picture quality, begin to be adopted by the PDP manufacturers. Hence, the market share of film-type optical filters for PDP was only 4% in fiscal 2004, but is estimated to jump to 40% for fiscal 2007.

In these circumstances, MCI was building a full-scale mass production facility at its Nagoya Works and launches commercial operations from April 2006 in accordance with a rise in demand for film-type optical filters and to sustain its top market share.

MCI will strengthen and expand the business as an industry leader of optical-filters for PDP by developing new products with innovative technologies and establishing a timely production system in accordance with the expanding PDP market.

http://www.mitsui-chem.co.jp/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.